Barbour, Abdelahhad
Bendayan, Yehoshua
Marks, Cara
Choi, Yan Hei Kelly
Oveisi, Morvarid
Callaghan, Mitchell
Sun, Chunxiang
Zargaran, Sina
Xia, Max
Wood, Dempsey
Smith, Leif
McLean, Jeffrey S.
Mazzulli, Tony
Glogauer, Michael
Funding for this research was provided by:
Natural Products Canada
Article History
Received: 18 November 2025
Accepted: 18 March 2026
First Online: 3 April 2026
Competing interests
: A.B. and M.G. are co-founders of Ostia Sciences Inc. They are inventors on patents related to phosphorylated lantibiotics and S. salivarius SALI-10 (USA: 18/837439; Europe: EP23752199.2A). They are also inventors on a provisional patent application related to sorbitol-mediated enhancement of phosphorylated lantibiotic production (United States Provisional Application No. 63/765,057). Y.B C.M., Y.K.C., and M.C. are employees at Ostia Sciences Inc. All other authors declare they have no competing interests.